Erick Siegenthaler, PharmD
Almost half of drugs approved by the FDA since January 2021 require IV, intramuscular or subcutaneous injection, according to a recent report by Bourne Partners (bit.ly/42KU3MV). This trend has driven growth in the infusion market, both in the home and ambulatory settings, an expert reported at the 2025 MHA Business Summit, in Orlando, Fla.
“Most drug discovery research today is focused on complex molecules that are infused biologics, as well as